MarketInOut Stock Screener Log In | Sign Up
 

LENSAR Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
LENSAR Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization73.96 mln
Float9.84 mln
Earnings Date11/05/2026

EPS

0.19
Overpriced

P / E

31.95
Overvalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

0.62
Highly suspicious

1-Year Forecast

11.33
Transformational upside

Relative Strength

37 / 100
Underperforming

Business Description

LENSAR Inc., founded in 2004 and based in Orlando, Florida, builds and sells advanced laser systems used by eye surgeons to treat cataracts and correct astigmatism across the United States, Europe, Asia, South Korea, and other markets. Its flagship product, the LENSAR Laser System, combines imaging, surgical planning, and precision tools to help surgeons achieve better patient outcomes. The company also offers the ALLY Robotic Cataract Laser System, a compact device that enables surgeons to carry out laser-assisted cataract procedures entirely within a single operating room.

Key Fundamentals

EPS0.19
P/E31.95
ROE883
RPS4.96
ROIC-18.97
ROA49.88
EBITDA, mln39.27
EV / EBITDA3.69
EV / EBIT4.18
Revenue, mln60.26
EV / Revenue2.40

Quote Details

Last 6.07
Change 0.05 (0.83%)
Open 5.98
Volume 28,418
Turnover 172,497
Average Volume 45,250

Financial Ratios

Pre-Tax Profit Margin58
Leverage Ratio4.67
Current Ratio2.39
Price / Book5.45
Price / Tangible Book7.94
Debt / Equity0.08
Price / Sales1.60

Financial Strength

Altman Z-Score1.46
Piotroski F-Score 5 / 9
Beneish M-Score0.62
1-Year Target Price11.33
Short Ratio4.90
Short % of Float3.63

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.66% 87 / 100   
1 Month -14.27% 24 / 100   
2 Months 5.57% 83 / 100   
6 Months 19.25% 89 / 100   
1 Year -50.33% 18 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog